Xiaoping Jin
Impact in
-
- Protease and Inhibitor Mechanisms
-
- Galectins and Cancer Biology
Papers in
-
- Protease and Inhibitor Mechanisms 9
-
- Blood Coagulation and Thrombosis Mechanisms 3
- Co-authors
- Xinwei He (8 shared papers)Xiaofei Hu (4 shared papers)Feng Wang (3 shared papers)Min Sheng Zhu (11 shared papers)Weiling Li (9 shared papers)Eileen Turcott (1 shared paper)Gregory J. Mize (1 shared paper)Li Cai (2 shared papers)
- Journals
- Scientific Reports (2 papers)Vascular Medicine (2 papers)Journal of Pharmaceutical Innovation (1 paper)Cell Biology and Toxicology (1 paper)Journal of the Neurological Sciences (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoping Jin
33 papers receiving 706 citations
Peers
Comparison fields: 5 of 97
- Cancer Research 76
- Immunology 109
- Molecular Biology 342
- Cardiology and Cardiovascular Medicine 54
- Nephrology 17
Countries citing papers authored by Xiaoping Jin
This map shows the geographic impact of Xiaoping Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Jin more than expected).
Fields of papers citing papers by Xiaoping Jin
This network shows the impact of papers produced by Xiaoping Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Jin. The network helps show where Xiaoping Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 96 | |
| 2 | 2019 | 82 | |
| 3 | 2011 | 75 | |
| 4 | 2017 | 64 | |
| 5 | 2003 | 62 | |
| 6 | 2016 | 49 | |
| 7 | 2019 | 45 | |
| 8 | 2012 | 38 | |
| 9 | 2017 | 23 | |
| 10 | Celastrol may have an anti-atherosclerosis effect in a rabbit experimental carotid atherosclerosis model. | 2014 | 18 |
| 11 | 2025 | 17 | |
| 12 | 2011 | 15 | |
| 13 | 2018 | 11 | |
| 14 | 2022 | 11 | |
| 15 | 2016 | 10 | |
| 16 | The association between the FABP2 Ala54Thr variant and the risk of type 2 diabetes mellitus: a meta-analysis based on 11 case-control studies. | 2015 | 9 |
| 17 | 2023 | 9 | |
| 18 | 2011 | 8 | |
| 19 | 2013 | 8 | |
| 20 | [Association of matrix metalloproteinase-3 serum level and the promoter 5A/6A polymorphism of the MMP-3 gene with atherosclerotic cerebral infarction]. | 2008 | 7 |
About Xiaoping Jin
Xiaoping Jin is a scholar working on Cancer Research, Hematology, Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine, having authored 34 papers that have together received 709 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), S100 Proteins and Annexins (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Peptidase Inhibition and Analysis (2 papers), Cardiac Fibrosis and Remodeling (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Nanoplatforms for cancer theranostics (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Cancer Research (76 citations), Immunology (109 citations), Molecular Biology (342 citations), Cardiology and Cardiovascular Medicine (54 citations) and Nephrology (17 citations). Xiaoping Jin has collaborated with scholars based in China and United States. Frequent co-authors include Xinwei He, Xiaofei Hu, Feng Wang, Min Sheng Zhu, Weiling Li, Eileen Turcott, Gregory J. Mize, Li Cai, David Morris and Guo‐Rong Chen. Their work appears in journals such as Scientific Reports, Vascular Medicine, Journal of Pharmaceutical Innovation, Cell Biology and Toxicology and Journal of the Neurological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.